5 Brain Cancer Clinical Trials in San Antonio, TX (2026)

Q: How do I join a clinical trial in San Antonio?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the San Antonio research site will contact you.

Recruiting Brain Cancer Studies in San Antonio

NCT05765812Recruiting

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

The primary purpose of the Phase 1 (Dose Escalation) of this study is to identify the dose-limiting toxicities (DLTs) of Debio 0123 combined with temozolomide (TMZ) (Arm A) and with TMZ and radiothera...

San Antonio, TXPHASE1116 participantsDebiopharm International SA

View Study Details

NCT01906385Recruiting

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

This is a multi-center, sequential cohort, open-label, volume and dose escalation study of the safety, tolerability, and distribution of 186RNL given by convection enhanced delivery to patients with r...

San Antonio, TXPHASE155 participantsPlus Therapeutics

View Study Details

NCT05460507Recruiting

Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment

This is an open-label, multicenter, Phase 1 study to establish the safety and efficacy/tolerability of a single dose of 186RNL by the intraventricular route (via intraventricular catheter) for recurre...

San Antonio, TXPHASE140 participantsPlus Therapeutics

View Study Details

NCT04559230Recruiting

Sacituzumab Govitecan in Recurrent Glioblastoma

This is an open-label single arm study. All patients will receive the study drug. The aim of the study is to compare overall survival (OS) of patients with recurrent brain tumor, known as Glioblastoma...

San Antonio, TXPHASE232 participantsThe University of Texas Health Science Center at San Antonio

View Study Details

NCT04863950Recruiting

Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma

This study is designed as a single center, prospective, open label, single-arm therapeutic trial with both surgical and non-surgical cohorts....

San Antonio, TXPHASE225 participantsThe University of Texas Health Science Center at San Antonio

View Study Details

About Brain Cancer Clinical Trials in San Antonio

Brain cancer includes tumors that originate in the brain (primary) or spread from other areas (metastatic). Glioblastoma (GBM) is the most common and aggressive primary brain tumor. Treatment typically combines surgery, radiation, and chemotherapy, with immunotherapy trials underway.

There are currently 5 brain cancer clinical trials recruiting participants in San Antonio, TX. These studies are seeking a combined 268 participants. Research is being sponsored by Debiopharm International SA, Plus Therapeutics, The University of Texas Health Science Center at San Antonio. Clinical trial participation is free and participants receive study-related medical care at no cost.

Brain Cancer Clinical Trials in San Antonio — FAQ

Are there brain cancer clinical trials in San Antonio?

Yes, there are 5 brain cancer clinical trials currently recruiting in San Antonio, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Antonio?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Antonio research site will contact you about next steps.

Are clinical trials in San Antonio free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Antonio studies also compensate for your time and travel.

What brain cancer treatments are being tested?

The 5 active trials in San Antonio are testing new therapies including novel drugs, biologics, and treatment approaches for brain cancer.

Data updated July 22, 2026 from ClinicalTrials.gov